AMR Utah formerly Pharmaceutical Research Organization, LLC

AMR Utah formerly Pharmaceutical Research Organization, LLC

研究服务

Bountiful，Utah 162 位关注者

Building a healthier future, one clinical trial at a time.

关注

关于我们

Pharmaceutical Research Organization is now AMR Utah. We conducts and manage the day-to-day clinical research trial at the investigative site level under the direction of the principal investigator. We handle all regulatory correspondence, contracts/budgets, and training/placement of study-dedicated research coordinators at the investigative site to recruit participants, gather data, complete documentation and follow study participants. The investigators we work with are not owned by our company, but are private practice physicians with established practices who contract with us on a protocol-to-protocol basis to assist them in conducting the trial at their clinical site. It is a symbiotic relationship that works extremely well for all parties.

网站
https://amrllc.com/
所属行业
研究服务
规模
11-50 人
总部
Bountiful，Utah
类型
合营企业
创立
2000
领域
Pediatric Vaccine Studies、Adult Vaccine Studies、Family Practice/Internal Medicine和Obstetrics and Gynecology

地点

  • 主要

    1596 S 500 W

    2nd Flr

    US，Utah，Bountiful，84010

    获取路线

AMR Utah formerly Pharmaceutical Research Organization, LLC员工

查看全部员工

动态

  • Welcome to the AMR team!

    查看AMR 的公司主页，图片
    AMR

    7,277 位关注者

    AMR Continues Expansion with Acquisition of Affinity Health Chicago, IL - Alliance for Multispecialty Research (AMR), a leading integrated research site organization, has acquired Affinity Health. Affinity Health, founded in 2015, provides clinical research delivery with exceptional patient care and safety. AMR’s acquisition of Affinity Health will continue to strengthen our position as an industry leader with 32 clinical research sites. According to CEO Bill Smith, MD, “This acquisition increases the AMR regional footprint and is another milestone in our goals around scalability and growth while maintaining our focus on patient centricity and patient diversity.” Over the last 8 years, Affinity Health has focused on advancing the reaches of medicine for the overall betterment of healthcare everywhere. “I am extremely excited to become part of AMR. This step allows our Affinity Health sites to enter the next phase of growth with stronger support in infrastructure and standardization as we support continued advancements in clinical development,” says Ali Ahmed, President, Affinity Health. Affinity’s clinical research centers offer specialized therapeutic focus as well as access to diverse patient populations. The addition of Affinity Health to AMR adds 8 new Principal Investigators to AMR with specialization across several key therapeutic areas. Together with their teams, they have experience in conducting research in Cardiology, Dermatology, Endocrinology, Internal Medicine, Orthopedics, Pulmonology, and Women's Health. AMR’s strategic acquisition of Affinity Health provides access to several key markets in Chicago, IL and Nashville, TN. “Identifying diverse clinical trial subjects continues to be a priority for AMR as we expand our capabilities geographically and therapeutically. The Affinity sites add additional depth in several key therapeutic areas such as Cardiology, Dermatology, and Endocrinology,” explained AMR Chief Operating Officer Kari Delahunty, MBA. For more information, visit www.amrllc.com or contact AMR directly at 615-591-0211. ABOUT AMR AMR is the leading independent site management company with a 30-year history of successfully executing clinical trials across a network of 32 clinical sites. The Company has over 130 dedicated principal investigators with more than 400 years of combined experience across 20+ therapeutic areas, providing its pharmaceutical sponsor and CRO clients unparalleled access to patients. AMR’s experience and scale allow it to deliver improved efficiencies and exceptional clinical quality. AMR is headquartered in Knoxville, Tennessee.

相似主页

查看职位